Home
About Us
Product Portfolio
News & Media
Careers

June 19, 2008 - Company Release
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

January 22, 2008 - Company Release
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor

  • News & Media
  • Press Releases 2007
  • Press Releases 2006
  • Press Releases 2005
  • Home

Copyright 2006-2008 Cerexa, Inc. All Rights Reserved   Legal Disclaimer | Privacy Statement | Site Map | Contact Us